Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK. (Q40732955)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Risk reducing salpingectomy and delayed oophorectomy in high risk women: views of cancer geneticists, genetic counsellors and gynaecological oncologists in the UK. (English)

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

object named as

Chris Jacobs

6

0 references

object named as

Usha Menon

2

0 references

Marc Tischkowitz

7

object named as

Marc Tischkowitz

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

author name string

Dhivya Chandrasekaran

1

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Robin Crawford

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Ertan Saridogan

5

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Elly Brockbank

8

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Jatinder Kalsi

9

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Davor Jurkovic

10

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Ranjit Manchanda

11

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

publication date

16 July 2015

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Familial Cancer

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

521-530

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Integrated genomic analyses of ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

BRCA mutation frequency and patterns of treatment response in BRCA mutation-positive women with ovarian cancer: a report from the Australian Ovarian Cancer Study Group

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

BRCA1 and BRCA2 mutations account for a large proportion of ovarian carcinoma cases

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Germline and somatic mutations in homologous recombination genes predict platinum response and survival in ovarian, fallopian tube, and peritoneal carcinomas

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Meta-analysis of BRCA1 and BRCA2 penetrance

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE.

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Characterization of BRCA1 and BRCA2 mutations in a large United States sample

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Screening for familial ovarian cancer: poor survival of BRCA1/2 related cancers

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Meta-analysis of risk reduction estimates associated with risk-reducing salpingo-oophorectomy in BRCA1 or BRCA2 mutation carriers

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

The association between early menopause and risk of ischaemic heart disease: influence of Hormone Therapy

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Increased cardiovascular mortality after early bilateral oophorectomy

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Metabolic syndrome after risk-reducing salpingo-oophorectomy in women at high risk for hereditary breast ovarian cancer: a controlled observational study

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Increased mortality for neurological and mental diseases following early bilateral oophorectomy

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Increased risk of parkinsonism in women who underwent oophorectomy before menopause.

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Quality-of-life effects of prophylactic salpingo-oophorectomy versus gynecologic screening among women at increased risk of hereditary ovarian cancer

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Survival patterns after oophorectomy in premenopausal women: a population-based cohort study.

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Factors influencing uptake and timing of risk reducing salpingo-oophorectomy in women at risk of familial ovarian cancer: a competing risk time to event analysis

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer.

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

The post-reproductive Fallopian tube: better removed?

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Radical fimbriectomy: A reasonable temporary risk-reducing surgery for selected women with a germ line mutation of BRCA 1 or 2 genes? Rationale and preliminary development

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Occult tubal carcinoma found at risk reducing salpingectomy in a BRCA1 carrier

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Does bilateral salpingectomy with ovarian retention warrant consideration as a temporary bridge to risk-reducing bilateral oophorectomy in BRCA1/2 mutation carriers?

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

New Strategies in Ovarian Cancer: Uptake and Experience of Women at High Risk of Ovarian Cancer Who Are Considering Risk-Reducing Salpingo-Oophorectomy

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Breast cancer risk after salpingo-oophorectomy in healthy BRCA1/2 mutation carriers: revisiting the evidence for risk reduction

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Breast and ovarian cancer risks to carriers of the BRCA1 5382insC and 185delAG and BRCA2 6174delT mutations: a combined analysis of 22 population based studies

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Risk-reducing salpingectomy with delayed oophorectomy in BRCA1/2 mutation carriers: patients' and professionals' perspectives

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Acceptability of prophylactic salpingectomy with delayed oophorectomy as risk-reducing surgery among BRCA mutation carriers

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Ovarian surface epithelium at the junction area contains a cancer-prone stem cell niche

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

The cell of origin of ovarian epithelial tumours

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Prophylactic salpingectomy and delayed oophorectomy as an alternative for BRCA mutation carriers

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Breast cancer-related preferences among women with and without BRCA mutations

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Medical oncologists' views on communicating with patients about chemotherapy costs: a pilot survey

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Combining web-based and mail surveys improves response rates: a PBRN study from PRIME Net.

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Internet versus mailed questionnaires: a controlled comparison (2).

1 reference

https://api.crossref.org/works/10.1007/S10689-015-9823-Y

21 January 2018

Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

1 reference

https://pubmed.ncbi.nlm.nih.gov/26178205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study

1 reference

https://pubmed.ncbi.nlm.nih.gov/26178205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Risk reducing salpingo-oophorectomy for BRCA mutation carriers: twenty years later

1 reference

https://pubmed.ncbi.nlm.nih.gov/26178205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The impact of hormone replacement therapy on menopausal symptoms in younger high-risk women after prophylactic salpingo-oophorectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/26178205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences in the characteristics of families with BRCA1 and BRCA2 mutations in Israel

1 reference

https://pubmed.ncbi.nlm.nih.gov/26178205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Penetrances of breast and ovarian cancer in a large series of families tested for BRCA1/2 mutations

1 reference

https://pubmed.ncbi.nlm.nih.gov/26178205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Frequencies of BRCA1 and BRCA2 mutations among 1,342 unselected patients with invasive ovarian cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26178205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Screening for familial ovarian cancer: the need for well-designed prospective studies

1 reference

https://pubmed.ncbi.nlm.nih.gov/26178205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of various methodologic strategies: survey response rates among Canadian physicians and physicians-in-training

1 reference

https://pubmed.ncbi.nlm.nih.gov/26178205

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10689-015-9823-Y

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40732955&oldid=2203932361"